Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time

    Gallwitz, B., Vaag, Allan, Falahati, A., Madsbad, Sten, Gallwitz, B., Vaag, A., Falahati, A. & Madsbad, Sten, 2010, In: International Journal of Clinical Practice. 64, 2, p. 267-76 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    At tro, at 50-60 årig ekan tabe sig, er naivt

    Madsbad, Sten, 2010, Diabetes inspiration til almen praksis. Dagens Medicin, p. 14-21 7 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  3. Published

    Desaturation of excess intramyocellular triacylglycerol in obesity: implications for glycemic control

    Haugaard, Steen Bendix, Madsbad, Sten, Mu, Huiling & Vaag, Allan, 2010, In: International Journal of Obesity. 34, 3, p. 500-510 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Desaturation of excess intramyocellular triacylglycerol in obesity: implications for glycemic control

    Haugaard, S. B., Madsbad, Sten, Mu, H. & Vaag, A., 1 Mar 2010, In: International Journal of Obesity. 34, 3, p. 500-10 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

    Asmar, M., Bache, M., Knop, Filip Krag, Madsbad, Sten & Holst, Jens Juul, 1 May 2010, In: The Journal of clinical endocrinology and metabolism. 95, 5, p. 2367-75 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients

    Kielgast, U., Asmar, M., Madsbad, Sten & Holst, Jens Juul, 2010, In: Journal of Clinical Endocrinology and Metabolism. 95, 5, p. 2492-6 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

    Knop, Filip Krag, Vilsbøll, Tina, Larsen, S., Madsbad, Sten, Holst, Jens Juul & Krarup, T. M., 24 Sep 2010, In: Regulatory Peptides. 164, 2-3, p. 144-50 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

    Christensen, M., Knop, Filip Krag, Vilsbøll, Tina, Aaboe, K., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 9 Aug 2010, In: Regulatory Peptides. 163, 1-3, p. 96-101 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans

    Asmar, M., Simonsen, L., Madsbad, Sten, Stallknecht, Bente Merete, Holst, Jens Juul & Bülow, J., 1 Sep 2010, In: Diabetes. 59, 9, p. 2160-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Insulin resistance and glucose intolerance independently reduce the incretin effect via a beta cell defect

    Jensen, D. H., Aaboe, K., Voelund, A., Henriksen, J. E., Holst, J. M., Madsbad, Sten & Krarup, T., 2010, In: Diabetologia. 53

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

Previous 1 2 3 Next

ID: 10877